A randomized controlled study of effectiveness between transcatheter arterial chemoembolization with fine powder cisplatin (IA-call) and transcatheter chemoembolization with Miriplatin for unresectable hepatocellular carcinomas(multicenter clinical trial PhaseII).
Phase of Trial: Phase II
Latest Information Update: 17 Oct 2014
At a glance
- Drugs Cisplatin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Apr 2011 New trial record